Patrys Patrys is a drug development company that commercializes antibody technologies for the treatment of cancer. | ![]() TRACON Pharmaceuticals TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration. | ||
Founding Date | Founding Date 2007 | Founding Date 1994 | Founding Date 2006 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations South Melbourne, AU HQ | Locations Alameda, US HQ | Locations San Diego, US HQ |
Employees | Employees N/A | Employees 1,14712% decrease | Employees 268% increase |
Valuation ($) | Valuation ($) 5.4 m | Valuation ($) 8.2 b | Valuation ($) 279.4 k |
Financial | |||
Revenue (est.) | Revenue (est.) $807k (FY, 2025) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $12m (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods $83.7m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $807k (FY, 2025) | Gross profit $2.2b (FY, 2025) | Gross profit N/A |
Net income | Net income ($3m) (FY, 2025) | Net income $782.6m (FY, 2025) | Net income ($3.6m) (FY, 2023) |

Exelixis is an oncology company that develops cancer treatments.
View company
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.
View company